Novartis Ag (NVS) Cash from Operations (2009 - 2025)
Novartis Ag's Cash from Operations came in at $5.88 billion for Q2 2026, down 11.7% from $6.66 billion a year earlier but up 60.0% from the prior quarter.
Novartis Ag (NVS) Cash from Operations (2009 - 2025) Analysis & Trends
Over the trailing twelve months to Jun 30, 2026, Novartis Ag reported Cash from Operations of $18.39 billion, down 11.5% year-over-year; for FY2025, it was $19.14 billion, up 8.7% from FY2024.
- Cash from Operations has increased in each of the last three years, with a five-year compound annual growth rate of 7.0% (FY2020 to FY2025).
- Going back by year, Cash from Operations was $17.62 billion in FY2024 (+21.9%), $14.46 billion in FY2023 (+1.6%), $14.24 billion in FY2022 (-5.5%) and $15.07 billion in FY2021 (+10.4%).
- The five-year range for quarterly Cash from Operations is $1.65 billion (Q1 2022) to $6.66 billion (Q2 2025).
- Year-over-year, Cash from Operations increased in six of the last eight quarters, with growth averaging 15.8%.
- The fastest year-over-year change in Cash from Operations over five years came in Q1 2023 (growth of 79.3%), and the weakest in Q4 2025 (a decline of 46.0%).
- Business Quant data shows NVS's Cash from Operations at $3.68 billion (Q1 2026), $2.26 billion (Q4 2025) and $6.57 billion (Q3 2025) in the three quarters before Q2 2026.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Ops. (Yr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | 16.81 Bn |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | 24.53 Bn |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | 19.03 Bn |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | 16.47 Bn |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | 19.14 Bn |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | 14.58 Bn |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | 9.96 Bn |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | 10.02 Bn |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | 11.70 Bn |
| 10 | Vertex Pharmaceuticals | 138.90 Bn | 106.64 Bn | 2.91 Bn | 3.63 Bn |
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | 19.14 Bn |
| Dec 31, 2024 | 17.62 Bn |
| Dec 31, 2023 | 14.46 Bn |
| Dec 31, 2022 | 14.24 Bn |
| Dec 31, 2021 | 15.07 Bn |
| Dec 31, 2020 | 13.65 Bn |
| Dec 31, 2019 | 13.63 Bn |
| Dec 31, 2018 | 14.27 Bn |
| Dec 31, 2017 | 12.62 Bn |
| Dec 31, 2016 | 11.48 Bn |
| Dec 31, 2015 | 12.09 Bn |
| Dec 31, 2014 | 13.90 Bn |
| Dec 31, 2013 | 13.17 Bn |
| Dec 31, 2012 | 5.50 Bn |
| Dec 31, 2011 | 14.31 Bn |
| Dec 31, 2010 | 14.07 Bn |
| Dec 31, 2009 | 12.19 Bn |
Novartis Ag Cash from Operations API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=cash-from-operations-annual&ticker=NVS&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "cash-from-operations-annual", "ticker": "NVS", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=cash-from-operations-annual&ticker=NVS&period=max&api_key=YOUR_API_KEY");
const data = await res.json();